Segment Information (Tables)

3 Months Ended

Mar. 31, 2019

Segment Information

Summary of results of operations by segment

	Dermatology		Contract		Corporate		Total
Quarter Ended March 31, 2019	Therapeutics		Research		and Other		Company
Revenue, net	$	3,778	$	5,190	$	(3,927)	$	5,041
Cost of revenue (excludes amortization)		1,570		5,037		(3,830)		2,777
Research and development		20,016		—		(97)		19,919
Sales and marketing		9,810		18		—		9,828
General and administrative		—		513		7,680		8,193
Amortization of definite-lived intangible		1,659		—		—		1,659
Loss from operations	$	(27,618)	$	(378)	$	(7,680)	$	(37,335)
	Dermatology		Contract		Corporate		Total
Quarter Ended March 31, 2018	Therapeutics		Research		and Other		Company
Revenue, net	$	—	$	2,502	$	(1,384)	$	1,118
Cost of revenue		—		2,120		(1,153)		967
Research and development		13,606		—		—		13,606
Sales and marketing		11,221		12		—		11,233
General and administrative		—		472		5,788		6,260
Loss from operations	$	(24,827)	$	(102)	$	(6,019)	$	(30,948)